Division of Cardiology, Department of Medicine, Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States.
Division of Cardiology, Department of Medicine, Center for Cardiovascular Biology, Institute for Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, United States.
J Mol Cell Cardiol. 2018 Aug;121:1-12. doi: 10.1016/j.yjmcc.2018.05.013. Epub 2018 May 22.
Mammalian cardiac myocytes (CMs) stop proliferating soon after birth and subsequent heart growth comes from hypertrophy, limiting the adult heart's regenerative potential after injury. The molecular events that mediate CM cell cycle exit are poorly understood. To determine the epigenetic mechanisms limiting CM cycling in adult CMs (ACMs) and whether trimethylation of lysine 9 of histone H3 (H3K9me3), a histone modification associated with repressed chromatin, is required for the silencing of cell cycle genes, we developed a transgenic mouse model where H3K9me3 is specifically removed in CMs by overexpression of histone demethylase, KDM4D. Although H3K9me3 is found across the genome, its loss in CMs preferentially disrupts cell cycle gene silencing. KDM4D binds directly to cell cycle genes and reduces H3K9me3 levels at these promotors. Loss of H3K9me3 preferentially leads to increased cell cycle gene expression resulting in enhanced CM cycling. Heart mass was increased in KDM4D overexpressing mice by postnatal day 14 (P14) and continued to increase until 9-weeks of age. ACM number, but not size, was significantly increased in KDM4D expressing hearts, suggesting CM hyperplasia accounts for the increased heart mass. Inducing KDM4D after normal development specifically in ACMs resulted in increased cell cycle gene expression and cycling. We demonstrated that H3K9me3 is required for CM cell cycle exit and terminal differentiation in ACMs. Depletion of H3K9me3 in adult hearts prevents and reverses permanent cell cycle exit and allows hyperplastic growth in adult hearts in vivo.
哺乳动物心肌细胞(CMs)在出生后不久停止增殖,随后的心脏生长来自于肥大,这限制了成年心脏在受伤后的再生潜力。介导 CM 细胞周期退出的分子事件还知之甚少。为了确定限制成年心肌细胞(ACMs)中 CM 周期的表观遗传机制,以及组蛋白 H3 赖氨酸 9 三甲基化(H3K9me3)是否是沉默细胞周期基因所必需的,我们开发了一种转基因小鼠模型,通过过表达组蛋白去甲基酶 KDM4D 特异性地在 CMs 中去除 H3K9me3。尽管 H3K9me3 存在于基因组的各个部位,但它在 CMs 中的缺失优先破坏细胞周期基因的沉默。KDM4D 直接与细胞周期基因结合,并降低这些启动子处的 H3K9me3 水平。H3K9me3 的缺失优先导致细胞周期基因表达增加,从而增强 CM 循环。KDM4D 过表达小鼠的心脏质量在出生后第 14 天(P14)增加,并持续增加到 9 周龄。KDM4D 表达心脏中 ACM 的数量增加,但大小没有显著增加,这表明 CM 增生导致心脏质量增加。在正常发育后,仅在 ACM 中诱导 KDM4D,可导致细胞周期基因表达和循环增加。我们证明了 H3K9me3 是 ACM 中 CM 细胞周期退出和终末分化所必需的。在成年心脏中耗尽 H3K9me3 可防止和逆转永久性细胞周期退出,并允许成年心脏在体内进行增生性生长。